Form 4: Healthcare Services Group Director Acquires Over 2,800 Deferred Stock Units

John J. McFadden JR, a Director at Healthcare Services Group Inc. (HCSG), has acquired 2,806 unvested deferred stock units valued at $14.26 per unit, signaling continued alignment with shareholder interests.

Summary

• John J. McFadden JR, a Director of Healthcare Services Group Inc. (HCSG), acquired 2,806 shares of Common Stock in the form of unvested deferred stock units (DSUs) on May 27, 2025.
• The acquisition price for these DSUs was $14.26 per unit.
• These DSUs will become fully vested on the one-year anniversary of the grant date, which is May 27, 2026.
• Settlement of these DSUs into shares of common stock will occur on the earliest of: the five-year anniversary of the grant date (May 27, 2030), the participant's date of death, disability, or separation from service, or the date of a Change of Control.
• Following this transaction, Mr. McFadden beneficially owns a total of 13,006 shares, comprising 2,806 unvested DSUs and 10,200 vested DSUs.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The acquisition of equity by a director, especially through a DSU grant, is generally a positive indicator of insider confidence and alignment with shareholder interests, contributing to a moderately positive sentiment.

Positives

• The acquisition of deferred stock units by a director indicates continued alignment of management's interests with those of shareholders.
• The grant of equity compensation is a common practice to incentivize and retain key personnel, including directors.
• The Rule 10b5-1 plan suggests a pre-planned, non-discretionary transaction, which can be viewed positively as it reduces concerns about opportunistic insider trading.

Future Outlook

The acquired deferred stock units are set to vest on May 27, 2026, and will be settled into common stock shares on the earliest of the five-year anniversary of the grant date (May 27, 2030), the participant's death, disability, separation from service, or a Change of Control. A participant may also elect a further deferral beyond the settlement date under Code Section 409A rules.

Management Comments

• The grant of 2,806 unvested deferred stock units to Director John J. McFadden JR reflects the company's compensation strategy to align director incentives with long-term shareholder value creation.

Industry Context

Insider transactions, such as the acquisition of equity by a director, are closely watched by investors as they can signal management's confidence in the company's future prospects. This type of equity grant is a standard practice in corporate compensation across various industries to foster long-term commitment and performance alignment.

Stakeholder Impact

• Shareholders: The transaction indicates continued alignment of a director's interests with shareholders, potentially boosting investor confidence.
• Employees: While not directly impacting employees, the compensation structure for directors can reflect broader company compensation philosophies.

Next Steps

• The unvested deferred stock units will vest on May 27, 2026.
• The DSUs will be settled into common stock shares on the earliest of the five-year anniversary of the grant date (May 27, 2030), the participant's death, disability, separation from service, or a Change of Control.

Key Dates

Recommendation

Keywords

Healthcare Services Group, HCSG, SEC Form 4, Insider Transaction, Deferred Stock Units, DSU, Equity Compensation, Director Stock Acquisition, Rule 10b5-1, Corporate Governance